Chlorpropamide

氯磺丙脲

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChlorpropamide
Drug Alias Name氯磺丙尿绿矿丙尿素氯丙二脒二苯氧基丙烷DiabenaseDiabinese
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSulfonylurea receptor agonists
TargetsSulfonylurea receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date1958/10/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesXi'An Disai Biological Pharmaceutical Co Ltd
Inactive CompaniesPfizer Inc
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BB02
Related LinksWikipediaDrugBankKEGG